UGT genomic diversity: beyond gene duplication

被引:117
作者
Guillemette, Chantal [1 ]
Levesque, Eric
Harvey, Mario
Bellemare, Judith
Menard, Vincent
机构
[1] CHUQ Res Ctr, Pharmacogen Lab, Canada Res Chair Pharmacogen, Quebec City, PQ G1V 4G2, Canada
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
HUMAN UDP-GLUCURONOSYLTRANSFERASES; HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; MESSENGER-RNA EXPRESSION; ACTIVATED-RECEPTOR-ALPHA; COPY-NUMBER-VARIATION; PREGNANE-X RECEPTOR; HUMAN-LIVER; PROSTATE-CANCER; DELETION POLYMORPHISM; IN-VITRO;
D O I
10.3109/03602530903210682
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The human uridine diphospho (UDP)-glucuronosyltransferase (UGT) superfamily comprises enzymes responsible for a major biotransformation phase II pathway: the glucuronidation process. The UGT enzymes are located in the endoplasmic reticulum of almost all tissues, where they catalyze the inactivation of several endogenous and exogenous molecules, including bilirubin, sex steroids, numerous prescribed drugs, and environmental toxins. This metabolic pathway is particularly variable. The influence of inheritable polymorphisms in human UGT-encoding genes has been extensively documented and was shown to be responsible for a fraction of the observed phenotypic variability. Other key genomic processes are likely underlying this diversity; these include copy-number variations, epigenetic factors, and newly discovered splicing mechanisms. This review will discuss novel molecular aspects that may be determinant to UGT phenotypes.</.
引用
收藏
页码:24 / 44
页数:21
相关论文
共 134 条
[51]   Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays [J].
Johnson, JM ;
Castle, J ;
Garrett-Engele, P ;
Kan, ZY ;
Loerch, PM ;
Armour, CD ;
Santos, R ;
Schadt, EE ;
Stoughton, R ;
Shoemaker, DD .
SCIENCE, 2003, 302 (5653) :2141-2144
[52]   Gene expression differences in normal esophageal mucosa associated with regression and progression of mild and moderate squamous dysplasia in a high-risk Chinese population [J].
Joshi, Nina ;
Johnson, Laura Lee ;
Wei, Wen-Qiang ;
Abnet, Christian C. ;
Dong, Zhi-Wei ;
Taylor, Philip R. ;
Limburg, Paul J. ;
Dawsey, Sanford M. ;
Hawk, Ernest T. ;
Qiao, You-Lin ;
Kirsch, Ilan R. .
CANCER RESEARCH, 2006, 66 (13) :6851-6860
[53]  
Jude AR, 2001, DRUG METAB DISPOS, V29, P652
[54]   Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22 [J].
Kampa, D ;
Cheng, J ;
Kapranov, P ;
Yamanaka, M ;
Brubaker, S ;
Cawley, S ;
Drenkow, J ;
Piccolboni, A ;
Bekiranov, S ;
Helt, G ;
Tammana, H ;
Gingeras, TR .
GENOME RESEARCH, 2004, 14 (03) :331-342
[55]   Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate [J].
Karypidis, A-H ;
Olsson, M. ;
Andersson, S-O ;
Rane, A. ;
Ekstrom, L. .
PHARMACOGENOMICS JOURNAL, 2008, 8 (02) :147-151
[56]   UDP-glucuronosyltransferases [J].
King, CD ;
Rios, GR ;
Green, MD ;
Tephly, TR .
CURRENT DRUG METABOLISM, 2000, 1 (02) :143-161
[57]   Promoter usage and alternative splicing [J].
Kornblihtt, AR .
CURRENT OPINION IN CELL BIOLOGY, 2005, 17 (03) :262-268
[58]   The interactions between the N-terminal and C-terminal domains of the human UDP-glucuronosyltransferases are partly isoform-specific, and may involve both monomers [J].
Kurkela, M ;
Hirvonen, J ;
Kostiainen, R ;
Finel, M .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (12) :2443-2450
[59]   Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs) [J].
Kurkela, M ;
García-Horsman, JA ;
Luukkanen, L ;
Mörsky, S ;
Taskinen, J ;
Baumann, M ;
Kostiainen, R ;
Hirvonen, J ;
Finel, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (06) :3536-3544
[60]   Interactions with other human UDP-glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6 [J].
Kurkela, Mika ;
Patana, Anne-Sisko ;
Mackenzie, Peter I. ;
Court, Michael H. ;
Tate, Christopher G. ;
Hirvonen, Jouni ;
Goldman, Adrian ;
Finel, Moshe .
PHARMACOGENETICS AND GENOMICS, 2007, 17 (02) :115-126